Shanghai Benemae Pharmaceutical Corporation
Shanghai Benemae Pharmaceutical is a privately held drugmaker focused on type 2 diabetes and obesity. Its lead product is beinaglutide, a GLP-1 agonist approved in China.
| Headquarters | Shanghai, China |
|---|---|
| Listing | Private |
| Lead asset / stage | beinaglutide Approved — China |
| Latest event | Benemae participated in the 18th Healthy China Forum. |